Re-Entering Antibacterial Drug Development

The Re-Entering Antibacterial Drug Development Summit is scheduled to take place November 16-18, 2015 in Boston, MA.

This Summit is designed as a forum for knowledge and opinion exchange between the major stakeholders, who are shaping the current state of antibacterial discovery and development.

Conference Overview

Track 1: Antibacterial Research and Development

• Novel Monoclonal Antibodies for the Prevention and Treatment of Bacterial Infections
• Antibiotic Adjuvants to Reclaim Legacy Drugs
• Trench Warfare: The Battle to Push Back the Lines of Gram-Negative Resistance
• New Antibiotics from Natural Products
• and more…

Track 2: Clinical Development and Commercialization of Antibacterials

• Overcoming the Challenges of Developing New Antibiotics for Resistant Bacteria with Regulatory Support and New Diagnostics
• Diagnostics Update: Recent Advances in Pathogen and Antimicrobial Resistance Detection
• Antibacterial Drug Development: The Role of Clinical Microbiology and the Need for Rapid Diagnostics
• The Contribution of Therapeutic Drug Monitoring to Clinical Trial Success and Effective Antibiotic Stewardship
• and more…

Track 3: Diagnostics to Guide Antimicrobial Stewardship and Drug Development

• Rapid DNA-Based Detection of Bacteria at the Point-of-Care Using a Portable Degas-Driven Microfluidic System
• RNA-Based Diagnosis of Antibiotic Resistance
• Luncheon Presentation: Rapid Clonal Diagnostics: Getting Personal with Pathogens at the Point of Care
• We are the World: How Pharmaceutical Industry Can Contribute to Antimicrobial Stewardship
• and more…

Please visit the Re-Entering Antibacterial Drug Development Summit website for more information and registration.